Diminished Susceptibility to Cefoperazone/Sulbactam and Piperacillin/Tazobactam in Enterobacteriaceae Due to Narrow-Spectrum β-Lactamases as Well as Omp Mutation

Aihara M, Nishida R, Akimoto M, Gotoh Y, Kiyosuke M, Uchiumi T, Nishioka M, Matsushima Y, Hayashi T, Kang D. Within-host evolution of a Klebsiella pneumoniae clone: selected mutations associated with the alteration of outer membrane protein expression conferred multidrug resistance. J Antimicrob Chem-other. 2021 Jan 19;76(2):362–369. https://doi.org/10.1093/jac/dkaa439 Aihara M Nishida R Akimoto M Gotoh Y Kiyosuke M Uchiumi T Nishioka M Matsushima Y Hayashi T Kang D Within-host evolution of a Klebsiella pneumoniae clone: selected mutations associated with the alteration of outer membrane protein expression conferred multidrug resistance J Antimicrob Chem-other 2021 Jan 1976 2 362 369 https://doi.org/10.1093/jac/dkaa43933099622Open DOISearch in Google Scholar

Bafna JA, Sans-Serramitjana E, Acosta-Gutiérrez S, Bodrenko IV, Hörömpöli D, Berscheid A, Brötz-Oesterhelt H, Winterhalter M, Ceccarelli M. Kanamycin uptake into Escherichia coli is facilitated by OmpF and OmpC porin channels located in the outer membrane. ACS Infect Dis. 2020 Jul 10;6(7):1855–1865. https://doi.org/10.1021/acsinfecdis.0c00102 Bafna JA Sans-Serramitjana E Acosta-Gutiérrez S Bodrenko IV Hörömpöli D Berscheid A Brötz-Oesterhelt H Winterhalter M Ceccarelli M Kanamycin uptake into Escherichia coli is facilitated by OmpF and OmpC porin channels located in the outer membrane ACS Infect Dis 2020 Jul 106 7 1855 1865 https://doi.org/10.1021/acsinfecdis.0c0010232369342Open DOISearch in Google Scholar

Chen Y, Xiang Q, Liu L. Comparison of antibiotic-associated diarrhea caused by cefoperazone/sulbactam or piperacillin/tazobactam in neurosurgery patients. J Int Med Res. 2021 May;49(5): 3000605211019661. https://doi.org/10.1177/03000605211019661 Chen Y Xiang Q Liu L Comparison of antibiotic-associated diarrhea caused by cefoperazone/sulbactam or piperacillin/tazobactam in neurosurgery patients J Int Med Res 2021 May49 5 3000605211019661 https://doi.org/10.1177/03000605211019661817029634057835Open DOISearch in Google Scholar

CLSI. Performance standards for antimicrobial susceptibility testing. 30th ed. CLSI supplement M100. Wayne (USA): Clinical and Laboratory Standards Institute; 2020. CLSI Performance standards for antimicrobial susceptibility testing. 30th ed. CLSI supplement M100 Wayne (USA) Clinical and Laboratory Standards Institute 2020Search in Google Scholar

Fournier B, Gravel A, Hooper DC, Roy PH. Strength and regulation of the different promoters for chromosomal beta-lactamases of Klebsiella oxytoca. Antimicrob Agents Chemother. 1999 Apr; 43(4): 850–855. https://doi.org/10.1128/AAC.43.4.850 Fournier B Gravel A Hooper DC Roy PH Strength and regulation of the different promoters for chromosomal beta-lactamases of Klebsiella oxytoca Antimicrob Agents Chemother 1999 Apr43 4 850 855 https://doi.org/10.1128/AAC.43.4.8508921610103190Open DOISearch in Google Scholar

Han MS, Park KS, Jeon JH, Lee JK, Lee JH, Choi EH, Lee SH. SHV Hyperproduction as a mechanism for piperacillin-tazobactam resistance in extended-spectrum cephalosporin-susceptible Klebsiella pneumoniae. Microb Drug Resist. 2020 Apr;26(4):334–340. https://doi.org/10.1089/mdr.2019.0079 Han MS Park KS Jeon JH Lee JK Lee JH Choi EH Lee SH SHV Hyperproduction as a mechanism for piperacillin-tazobactam resistance in extended-spectrum cephalosporin-susceptible Klebsiella pneumoniae Microb Drug Resist 2020 Apr26 4 334 340 https://doi.org/10.1089/mdr.2019.007931651221Open DOISearch in Google Scholar

Hubbard ATM, Mason J, Roberts P, Parry CM, Corless C, van Aartsen J, Howard A, Bulgasim I, Fraser AJ, Adams ER, et al. Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of bla_TEM-1B. Nat Commun. 2020 Oct 1;11(1):4915. https://doi.org/10.1038/s41467-020-18668-2 Hubbard ATM Mason J Roberts P Parry CM Corless C van Aartsen J Howard A Bulgasim I Fraser AJ Adams ER et al Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of bla_TEM-1B Nat Commun 2020 Oct 111 1 4915 https://doi.org/10.1038/s41467-020-18668-2753076233004811Open DOISearch in Google Scholar

Joshi P, Shrivastava R, Bhagwat S, Patel M. Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases. Diagn Microbiol Infect Dis. 2021 Oct;101(2):115481. https://doi.org/10.1016/j.diagmicrobio.2021.115481 Joshi P Shrivastava R Bhagwat S Patel M Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases Diagn Microbiol Infect Dis 2021 Oct101 2 115481 https://doi.org/10.1016/j.diagmicrobio.2021.11548134332307Open DOISearch in Google Scholar

Kashefieh M, Hosainzadegan H, Baghbanijavid S, Ghotaslou R. The molecular epidemiology of resistance to antibiotics among Klebsiella pneumoniae isolates in Azerbaijan, Iran. J Trop Med. 2021 Jul 12;2021:9195184. https://doi.org/10.1155/2021/9195184 Kashefieh M Hosainzadegan H Baghbanijavid S Ghotaslou R The molecular epidemiology of resistance to antibiotics among Klebsiella pneumoniae isolates in Azerbaijan, Iran J Trop Med 2021 Jul 1220219195184 https://doi.org/10.1155/2021/9195184829496434335793Open DOISearch in Google Scholar

Kuo SC, Wang YC, Tan MC, Huang WC, Shiau YR, Wang HY, Lai JF, Huang IW, Lauderdale TL. In vitro activity of imipenem/ relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan. J Antimicrob Chemother. 2021 Jul 15;76(8):2071–2078. https://doi.org/10.1093/jac/dkab141 Kuo SC Wang YC Tan MC Huang WC Shiau YR Wang HY Lai JF Huang IW Lauderdale TL In vitro activity of imipenem/ relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan J Antimicrob Chemother 2021 Jul 1576 8 2071 2078 https://doi.org/10.1093/jac/dkab141856126533956969Open DOISearch in Google Scholar

Martínez-Martínez L. Extended-spectrum beta-lactamases and the permeability barrier. Clin Microbiol Infect. 2008 Jan;14(Suppl 1): 82–89. https://doi.org/10.1111/j.1469-0691.2007.01860.x Martínez-Martínez L. Extended-spectrum beta-lactamases and the permeability barrier Clin Microbiol Infect 2008 Jan14 Suppl 1 82 89 https://doi.org/10.1111/j.1469-0691.2007.01860.x18154531Open DOISearch in Google Scholar

Morroni G, Bressan R, Fioriti S, D’Achille G, Mingoia M, Cirioni O, Di Bella S, Piazza A, Comandatore F, Mauri C, et al. Antimicrobial activity of aztreonam in combination with old and new β-lactamase inhibitors against MBL and ESBL co-producing Gram-Negative clinical isolates: possible options for the treatment of complicated infections. Antibiotics (Basel). 2021 Nov 3;10(11):1341. https://doi.org/10.3390/antibiotics10111341 Morroni G Bressan R Fioriti S D’Achille G Mingoia M Cirioni O Di Bella S Piazza A Comandatore F Mauri C et al Antimicrobial activity of aztreonam in combination with old and new β-lactamase inhibitors against MBL and ESBL co-producing Gram-Negative clinical isolates: possible options for the treatment of complicated infections Antibiotics (Basel) 2021 Nov 310 11 1341 https://doi.org/10.3390/antibiotics10111341861500034827279Open DOISearch in Google Scholar

Noguchi T, Matsumura Y, Kanahashi T, Tanaka M, Tsuchido Y, Matsumura T, Nakano S, Yamamoto M, Nagao M, Ichiyama S. Role of TEM-1 β-lactamase in the predominance of ampicillin-sulbactam-nonsusceptible Escherichia coli in Japan. Antimicrob Agents Chemother. 2019 Jan 29;63(2):e02366-18. https://doi.org/10.1128/AAC.02366-18 Noguchi T Matsumura Y Kanahashi T Tanaka M Tsuchido Y Matsumura T Nakano S Yamamoto M Nagao M Ichiyama S Role of TEM-1 β-lactamase in the predominance of ampicillin-sulbactam-nonsusceptible Escherichia coli in Japan Antimicrob Agents Chemother 2019 Jan 2963 2 e02366 18 https://doi.org/10.1128/AAC.02366-18635557230455244Open DOISearch in Google Scholar

Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: A clinical update. Clin Microbiol Rev. 2005 Oct;18(4):657–686. https://doi.org/10.1128/CMR.18.4.657-686.2005 Paterson DL Bonomo RA Extended-spectrum beta-lactamases: A clinical update Clin Microbiol Rev 2005 Oct18 4 657 686 https://doi.org/10.1128/CMR.18.4.657-686.2005126590816223952Open DOISearch in Google Scholar

Ramdani-Bouguessa N, Manageiro V, Jones-Dias D, Ferreira E, Tazir M, Caniça M. Role of SHV β-lactamase variants in resistance of clinical Klebsiella pneumoniae strains to β-lactams in an Algerian hospital. J Med Microbiol. 2011 Jul;60(Pt 7):983–987. https://doi.org/10.1099/jmm.0.030577-0 Ramdani-Bouguessa N Manageiro V Jones-Dias D Ferreira E Tazir M Caniça M Role of SHV β-lactamase variants in resistance of clinical Klebsiella pneumoniae strains to β-lactams in an Algerian hospital J Med Microbiol 2011 Jul60 Pt 7 983 987 https://doi.org/10.1099/jmm.0.030577-0316821621415202Open DOISearch in Google Scholar

Rehman N, Azam S, Ali A, Khan I, Asghar M, Ali M, Waqas M, Ullah F, Sehra GE. Molecular epidemiology of antibiotic-resistant genes and potent inhibitors against TEM, CTX-M-14, CTX-M-15, and SHV-1 proteins of Escherichia coli in district Peshawar, Pakistan. Saudi J Biol Sci. 2021 Nov;28(11):6568–6581. https://doi.org/10.1016/j.sjbs.2021.07.028 Rehman N Azam S Ali A Khan I Asghar M Ali M Waqas M Ullah F Sehra GE Molecular epidemiology of antibiotic-resistant genes and potent inhibitors against TEM, CTX-M-14, CTX-M-15, and SHV-1 proteins of Escherichia coli in district Peshawar, Pakistan Saudi J Biol Sci 2021 Nov28 11 6568 6581 https://doi.org/10.1016/j.sjbs.2021.07.028856900134764772Open DOISearch in Google Scholar

Schechter LM, Creely DP, Garner CD, Shortridge D, Nguyen H, Chen L, Hanson BM, Sodergren E, Weinstock GM, Dunne WM Jr, et al. Extensive gene amplification as a mechanism for piperacillintazobactam resistance in Escherichia coli. mBio. 2018 Apr 24;9(2): e00583-18. https://doi.org/10.1128/mBio.00583-18 Schechter LM Creely DP Garner CD Shortridge D Nguyen H Chen L Hanson BM Sodergren E Weinstock GM Dunne WM Jr et al Extensive gene amplification as a mechanism for piperacillintazobactam resistance in Escherichia coli mBio 2018 Apr 249 2 e00583 18 https://doi.org/10.1128/mBio.00583-18591573129691340Open DOISearch in Google Scholar

Stewart AG, Price EP, Schabacker K, Birikmen M, Harris PNA, Choong K, Subedi S, Sarovich DS. Molecular epidemiology of third-generation cephalosporin-resistant Enterobacteriaceae in Southeast Queensland, Australia. Antimicrob Agents Chemother. 2021 May 18;65(6):e00130-21. https://doi.org/10.1128/AAC.00130-21 Stewart AG Price EP Schabacker K Birikmen M Harris PNA Choong K Subedi S Sarovich DS Molecular epidemiology of third-generation cephalosporin-resistant Enterobacteriaceae in Southeast Queensland, Australia Antimicrob Agents Chemother 2021 May 1865 6 e00130 21 https://doi.org/10.1128/AAC.00130-21831590833781999Open DOISearch in Google Scholar

Sun J, Wang Y, Ni YX. [Hyperproduction of TEM-1 β-lactamase mediates the resistance of Escherichia coli to piperacillin-tazobactam and cefoperazone] (in Chinese). Chin J Infect Chemother. 2013 May;13(3):167–172. https://doi.org/10.16718/j.1009-7708.2013.03.003 Sun J Wang Y Ni YX [Hyperproduction of TEM-1 β-lactamase mediates the resistance of Escherichia coli to piperacillin-tazobactam and cefoperazone] (in Chinese) Chin J Infect Chemother 2013 May13 3 167 172 https://doi.org/10.16718/j.1009-7708.2013.03.003Open DOISearch in Google Scholar

Thomson KS, AbdelGhani S, Snyder JW, Thomson GK. Activity of cefepime-zidebactam against multidrug-resistant (MDR) Gram-Negative pathogens. Antibiotics (Basel). 2019 Mar 23;8(1):32. https://doi.org/10.3390/antibiotics8010032 Thomson KS AbdelGhani S Snyder JW Thomson GK Activity of cefepime-zidebactam against multidrug-resistant (MDR) Gram-Negative pathogens Antibiotics (Basel) 2019 Mar 238 1 32 https://doi.org/10.3390/antibiotics8010032646658630909535Open DOISearch in Google Scholar

Tian X, Wang Q, Perlaza-Jiménez L, Zheng X, Zhao Y, Dhanasekaran V, Fang R, Li J, Wang C, Liu H, Lithgow T, Cao J, Zhou T. First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling. BMC Microbiol. 2020 Jul 20;20(1):218. https://doi.org/10.1186/s12866-020-01898-1 Tian X Wang Q Perlaza-Jiménez L Zheng X Zhao Y Dhanasekaran V Fang R Li J Wang C Liu H Lithgow T Cao J Zhou T First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling BMC Microbiol 2020 Jul 2020 1 218 https://doi.org/10.1186/s12866-020-01898-1737280732689945Open DOISearch in Google Scholar

Winkler ML, Papp-Wallace KM, Taracila MA, Bonomo RA. Avibactam and inhibitor-resistant SHV β-lactamases. Antimicrob Agents Chemother. 2015 Jul;59(7):3700–3709. https://doi.org/10.1128/AAC.04405-14 Winkler ML Papp-Wallace KM Taracila MA Bonomo RA Avibactam and inhibitor-resistant SHV β-lactamases Antimicrob Agents Chemother 2015 Jul59 7 3700 3709 https://doi.org/10.1128/AAC.04405-14446874125691639Open DOISearch in Google Scholar

Zhou K, Tao Y, Han L, Ni Y, Sun J. Piperacillin-tazobactam (TZP) resistance in Escherichia coli due to hyperproduction of TEM-1 β-Lactamase mediated by the promoter Pa/Pb. Front Microbiol. 2019 Apr 16;10:833. https://doi.org/10.3389/fmicb.2019.00833 Zhou K Tao Y Han L Ni Y Sun J Piperacillin-tazobactam (TZP) resistance in Escherichia coli due to hyperproduction of TEM-1 β-Lactamase mediated by the promoter Pa/Pb Front Microbiol 2019 Apr 1610833 https://doi.org/10.3389/fmicb.2019.00833647696731040841Open DOISearch in Google Scholar